Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kosta Theodorou

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Frontiers in Cell and Developmental Biology|August 23, 2018
Endothelial Cell Metabolism in AtherosclerosisKosta Theodorou, Reinier A Boon
Expert Review of Cardiovascular Therapy|March 29, 2017
HDL and macrophages: explaining the clinical failures and advancing HDL-based therapeutics in cardiovascular diseases?Emiel P C van der Vorst, Kosta Theodorou, Erik A L Biessen, et al.
Cell Metabolism|June 27, 2017
Disease- or Storage-Associated Structural Modifications Are Unlikely to Explain HDL Pro-inflammatory Effects on MacrophagesEmiel P C van der Vorst, Kosta Theodorou, Erik A L Biessen, et al.
Cardiovascular Research|August 15, 2018
Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signallingPatrick Hofmann, Janina Sommer, Kosta Theodorou, et al.
The Journal of Experimental Medicine|March 2, 2019
Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysisTorben Mentrup, Kosta Theodorou, Florencia Cabrera-Cabrera, et al.
Plos One|September 29, 2022
Aging-regulated TUG1 is dispensable for endothelial cell functionAnna Theresa Gimbel, Susanne Koziarek, Kosta Theodorou, et al.
Scientific Reports|March 29, 2017
Adventitial lymphatic capillary expansion impacts on plaque T cell accumulation in atherosclerosisTimo Rademakers, Emiel P C van der Vorst, Isabelle T M N Daissormont, et al.
Frontiers in Cardiovascular Medicine|February 13, 2023
Endothelial ADAM10 controls cellular response to oxLDL and its deficiency exacerbates atherosclerosis with intraplaque hemorrhage and neovascularization in miceEmiel P C van der Vorst, Sanne L Maas, Kosta Theodorou, et al.
Scientific Reports|September 17, 2017
Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progressionKosta Theodorou, Emiel P C van der Vorst, Marion J Gijbels, et al.
The American Journal of Pathology|February 10, 2015
Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosisEmiel P C van der Vorst, Mike Jeurissen, Ine M J Wolfs, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Frontiers in Cell and Developmental Biology|August 23, 2018
Endothelial Cell Metabolism in AtherosclerosisKosta Theodorou, Reinier A Boon
Expert Review of Cardiovascular Therapy|March 29, 2017
HDL and macrophages: explaining the clinical failures and advancing HDL-based therapeutics in cardiovascular diseases?Emiel P C van der Vorst, Kosta Theodorou, Erik A L Biessen, et al.
Cell Metabolism|June 27, 2017
Disease- or Storage-Associated Structural Modifications Are Unlikely to Explain HDL Pro-inflammatory Effects on MacrophagesEmiel P C van der Vorst, Kosta Theodorou, Erik A L Biessen, et al.
Cardiovascular Research|August 15, 2018
Long non-coding RNA H19 regulates endothelial cell aging via inhibition of STAT3 signallingPatrick Hofmann, Janina Sommer, Kosta Theodorou, et al.
The Journal of Experimental Medicine|March 2, 2019
Atherogenic LOX-1 signaling is controlled by SPPL2-mediated intramembrane proteolysisTorben Mentrup, Kosta Theodorou, Florencia Cabrera-Cabrera, et al.
Plos One|September 29, 2022
Aging-regulated TUG1 is dispensable for endothelial cell functionAnna Theresa Gimbel, Susanne Koziarek, Kosta Theodorou, et al.
Scientific Reports|March 29, 2017
Adventitial lymphatic capillary expansion impacts on plaque T cell accumulation in atherosclerosisTimo Rademakers, Emiel P C van der Vorst, Isabelle T M N Daissormont, et al.
Frontiers in Cardiovascular Medicine|February 13, 2023
Endothelial ADAM10 controls cellular response to oxLDL and its deficiency exacerbates atherosclerosis with intraplaque hemorrhage and neovascularization in miceEmiel P C van der Vorst, Sanne L Maas, Kosta Theodorou, et al.
Scientific Reports|September 17, 2017
Whole body and hematopoietic ADAM8 deficiency does not influence advanced atherosclerotic lesion development, despite its association with human plaque progressionKosta Theodorou, Emiel P C van der Vorst, Marion J Gijbels, et al.
The American Journal of Pathology|February 10, 2015
Myeloid A disintegrin and metalloproteinase domain 10 deficiency modulates atherosclerotic plaque composition by shifting the balance from inflammation toward fibrosisEmiel P C van der Vorst, Mike Jeurissen, Ine M J Wolfs, et al.
Pageof 2